SNWV — SANUWAVE Health, Inc. Common Stock
NASDAQ · Healthcare · Medical Devices
$4.60
-$0.09 (-1.92%)
SANUWAVE Health, Inc. Common Stock (SNWV) is a medical devices company listed on NASDAQ. It is led by Morgan C. Frank, based in 9600 W. 76th Street, Eden Prairie, MN, United States, 55344, with about 55 employees. SANUWAVE Health, Inc. operates as a medical device company in the United States and internationally. It focuses on the commercialization of regenerative medicines through noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company markets UltraMist system, a medical device that uses non-thermal ultrasound to treat tissues using a fluid mist to transmit energy in a non-contact and pain free way for use in the treatment of acute and chronic wounds. The company was founded in 2004 and is headquartered in Eden Prairie, Minnesota.
Latest reported SNWV revenue for 2025-09-30 was $11.5M. Net income was $10.3M. Revenue was up 12.7% from 2025-06-30 to 2025-09-30. SNWV currently screens at market cap $78.2M and trailing P/E 9.5.
Use this SNWV page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the SNWV quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the SNWV SEC filings page. Lician reads the product cache first so this HTML stays unique to SANUWAVE Health, Inc. Common Stock even when a live quote feed is slow.
About SANUWAVE Health, Inc. Common Stock
SANUWAVE Health, Inc. operates as a medical device company in the United States and internationally. It focuses on the commercialization of regenerative medicines through noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company markets UltraMist system, a medical device that uses non-thermal ultrasound to treat tissues using a fluid mist to transmit energy in a non-contact and pain free way for use in the treatment of acute and chronic wounds. The company was founded in 2004 and is headquartered in Eden Prairie, Minnesota.
SNWV Key Statistics
Market Cap
$78.16M
Volume
45,059
Previous Close
$4.87
Day Range
$4.66 – $4.87
P/E Ratio
9.47
P/B Ratio
42.71
EPS
-$7.03
Revenue
$32.63M
Net Income
-$31.37M
Gross Profit
$0.00
Free Cash Flow
$0.00
Revenue Growth
+60.0%
Profit Margin
-96.1%
Employees
55
SNWV Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Revenue | $32.63M | $20.40M | $16.74M |
| Cost of Revenue | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 |
| Net Income | -$31.37M | -$25.81M | -$10.29M |
| EPS (Diluted) | -$7.03 | -$12.19 | -$0.02 |
Total Assets
$30.12M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$10.24M
Operating Cash Flow
$2.46M
Free Cash Flow
$0.00
SANUWAVE Health, Inc. Common Stock Company Information
- CEO & Chairman
- Morgan C. Frank
- Headquarters
- 9600 W. 76th Street, Eden Prairie, MN, United States, 55344
- Website
- sanuwave.com
- Phone
- 952 656 1029
- IPO / Founded
- 2015-03-10
- Sector
- Healthcare
- Industry
- Medical Devices